Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 148 of the 151 references it cites were found in a registry or an index.

Management of Type 1 Diabetes in Pregnancy

Open access
Feldman, Anna Z., Brown, Florence M. · 2016 · Current Diabetes Reports

Abstract

Women with type 1 diabetes (T1DM) have unique needs during the preconception, pregnancy, and postpartum periods. Preconception counseling is essential for women with T1DM to minimize pregnancy risks. The goals of preconception care should be tight glycemic control with a hemoglobin A1c (A1C) < 7 % and as close to 6 % as possible, without significant hypoglycemia. This will lower risks of congenital malformations, preeclampsia, and perinatal mortality. The safety of medications should be assessed prior to conception. Optimal control of retinopathy, hypertension, and nephropathy should be achieved. During pregnancy, the goal A1C is near-normal at <6 %, without excessive hypoglycemia. There is no clear evidence that continuous subcutaneous insulin infusion (CSII) versus multiple daily injections (MDI) is superior in achieving the desired tight glycemic control of T1DM during pregnancy. Data regarding continuous glucose monitoring (CGM) in pregnant women with T1DM is conflicting regarding improved glycemic control. However, a recent CGM study does provide some distinct patterns of glucose levels associated with large for gestational age infants. Frequent eye exams during pregnancy are essential due to risk of progression of retinopathy during pregnancy. Chronic hypertension treatment goals are systolic blood pressure 110-129 mmHg and diastolic blood pressure 65-79 mmHg. Labor and delivery target plasma glucose levels are 80-110 mg/dl, and an insulin drip is recommended to achieve these targets during active labor. Postpartum, insulin doses must be reduced and glucoses closely monitored in women with T1DM because of the enhanced insulin sensitivity after delivery. Breastfeeding is recommended and should be highly encouraged due to maternal benefits including increased insulin sensitivity and weight loss and infant and childhood benefits including reduced prevalence of overweight. In this article, we discuss the care of pregnant patients with T1DM.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11892-016-0765-z

Cites

148 of 148 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Preconception A1C vs absolute risk of congenital anomaly (with permission from American Diabetes Association: Guerin A, Nisenbaum R, Ray JG. Use of maternal GHb concentration to estimate the risk of congenital anomalies in the offspring of women with prepregnancy diabetes. Diabetes Care 2007;30:1920-5. Copyright and all rights reserved. Material from this publication has been used with the permission of American Diabetes Association) [2]
Fig. 1 Preconception A1C vs absolute risk of congenital anomaly (with permission from American Diabetes Association: Guerin A, Nisenbaum R, Ray JG. Use of maternal GHb concentration to estimate the risk of congenital anomalies in the offspring of women with prepregnancy diabetes. Diabetes Care 2007;30:1920-5. Copyright and all rights reserved. Material from this publication has been used with the permission of American Diabetes Association) [2]CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 151 references

Research works printed but not linked: 3

  1. Reader D, Thomas AM. Medical nutrition therapy: goals for pregnancy complicated by pre-existing diabetes mellitus. In: Kitzmiller JL, Jovanovic LB, Brown FM, Coustan DR, Reader D, editors. Managing preexisting diabetes and pregnancy: technical reviews and consensus recommendations. Alexandria: ADA; 2008.
  2. Trevathan WR, Smith EO, McKenna J, editors. Evolutionary medicine and health, new perspectives. New York: Oxford University Press; 2007.
  3. Kjos SL. Contraception for women with diabetes, in diabetes in women. In: Tsatsoulis A, Wyckoff J, Brown FM, editors. Pathophysiology and therapy. New York: Humana press; 2009.

Cited by

See all 65

Metadata

Authors
Feldman, A. Z., & Brown, F. M.
Affiliations
Joslin Diabetes Center (US)
Corresponding author
Brown, Florence M.
Venue
Current Diabetes Reports
Published
2016-06-24
Volume
16
Issue
8
Pages
76-76
ISSN
  • 1534-4827 (ISSN-L)
  • 1539-0829
OpenAlex
W2464657284
Cited by
65
References
151
Citations by year
2026: 7 · 2025: 3 · 2024: 2 · 2023: 11 · 2022: 5 · 2021: 6 · 2020: 6 · 2019: 9 · 2018: 8 · 2017: 8
FWCI
1.47
Type
journal article
Language
en
Open access
Locations
  • Current Diabetes Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
type 1 diabetes, pregnancy, preconception care, glycemic control, HbA1c, hypoglycemia, insulin pump therapy, multiple daily insulin injections, continuous glucose monitoring, diabetic retinopathy, hypertension in pregnancy, breastfeeding, congenital malformations, preeclampsia, perinatal mortality
MeSH terms
Counseling, Diabetes Mellitus, Type 1, Female, Humans, Insulin, Pregnancy, Pregnancy in Diabetics, Preconception Care, Postpartum Period

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Management of Type 1 Diabetes in Pregnancy. https://app.cochat.ai/papers/10.1007/s11892-016-0765-z
The paper
Feldman, A. Z., & Brown, F. M. (2016). Management of Type 1 Diabetes in Pregnancy. Current Diabetes Reports. https://doi.org/10.1007/s11892-016-0765-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.